Bacalso, Princess Star .

HRN: 23-93-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/21/2023
10/24/2023
IV
500mg
Q8hrs X 3 Days
S/P Primary LSTCS; Thickly MSAF
Checking Final Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Initial appropriateness: Yes     

Intervention



 Type of Intervention done:

                    

           


 Acceptance: